Apto-Turinabol (Extra) Beligas at a Glance
Apto-Turinabol (Extra) Beligas is an oral anabolic steroid research compound manufactured by Beligas Pharmaceuticals for in-vitro laboratory studies. This chlorodehydromethyltestosterone derivative belongs to the 17α-alkylated steroid class, offering researchers a valuable tool for investigating androgenic and anabolic pathways. The compound demonstrates modified binding characteristics at androgen receptors compared to testosterone, making it suitable for examining tissue-selective effects in controlled research environments. Laboratory professionals studying hormonal modulation pathways will find this compound particularly useful for comparative analyses with other androgenic compounds available through Stroid UK Shop.
Laboratory Research Applications
Research scientists examine Apto-Turinabol for its unique structural modifications that affect receptor binding affinity and metabolic stability. The compound’s 4-chloro substitution creates distinct pharmacokinetic properties that researchers study in muscle tissue culture models and hepatic metabolism investigations. Laboratories specialising in turinabol oral steroids research utilise this compound to evaluate protein synthesis pathways and nitrogen retention mechanisms. The modified structure allows researchers to investigate selective tissue targeting compared to natural testosterone, providing insights into androgenic versus anabolic activity ratios. Studies often compare this compound with SARMs to understand different mechanisms of androgen receptor modulation.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | 4-chlorodehydromethyltestosterone |
| Molecular Formula | C₂₀H₂₇ClO₂ |
| Molecular Weight | 334.89 g/mol |
| CAS Number | Verify with supplier |
| Manufacturer | Beligas Pharmaceuticals |
| Form | Oral tablets |
| Storage | Room temperature, dry conditions |
Research facilities examining metabolic modulators often cross-reference this compound with peptides to understand different approaches to tissue growth modulation. The oral bioavailability characteristics make it particularly valuable for studying hepatic first-pass metabolism effects in laboratory models.
Research Use Compliance
Apto-Turinabol (Extra) Beligas is manufactured exclusively for in-vitro research purposes and laboratory investigations. This compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Research institutions must ensure proper licensing and safety protocols when handling this material. All studies should be conducted by qualified personnel with appropriate analytical equipment for compound verification and purity testing. Researchers must maintain detailed documentation of storage conditions and handling procedures according to laboratory safety standards.
